Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Novel rat models of doxorubicin-induced left ventricular dysfunction

Dec. 2, 2020

Investigators develop a swine model of abdominal aortic aneurysm

Dec. 2, 2020

New KCNT1 inhibitors identified at Praxis Precision Medicines

Dec. 1, 2020

Results of a phase Ib trial evaluating the microR-132 inhibitor CDR-132L in heart failure

Nov. 30, 2020

RAP-011: a sotatercept analogue active in in vivo models of PAH

Nov. 23, 2020

Sotatercept for RV-PA coupling and RV function improvement in PAH

Nov. 20, 2020

Phase I data presented for AMG-890 in patients with elevated plasma Lp(a)

Nov. 19, 2020

Peptide-conjugated ReNcell-derived EVs: a new therapeutic approach for pulmonary hypertension

Nov. 19, 2020

FDA accepts IND application for LY-3561774

Nov. 18, 2020

First-in-human interim results of ALN-AGT01 in patients with hypertension

Nov. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...